Top Markets
Coin of the day
Allergy Therapeutics plc Allergy Therapeutics plc

Allergy Therapeutics plc

AGY
Classificação em ações #35053
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and... Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
Preço da ação
$0.07143683
Última sincronização: 2026-08-14
Valor de mercado
$4.52M
Variação (1 dia)
0.00%
Variação (1 ano)
-37.27%
País
GB
Negociar Allergy Therapeutics plc (AGY)

Categoria

Histórico de dividendos de Allergy Therapeutics plc (AGY)
Allergy Therapeutics plc (símbolo da ação: AGY) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Allergy Therapeutics plc (AGY) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes